Characterization of preeclampsia in the Province of Villa Clara
Abstract
Introduction: Preeclampsia is a complex, progressive, multi-causal multisystem syndrome of variable severity and highly heterogeneous evolution. It is one of the most serious conditions in pregnancy and a major cause of maternal and perinatal morbidity and mortality. It is considered a process of immunological maladaptation, with local and systemic inflammation and significant endothelial dysfunction.
Objective: To characterize patients with preeclampsia, from a clinical, epidemiological, and immunological perspective, who attended the "Mariana Grajales" Gynecological-Obstetric Hospital in Villa Clara province, from January 2019 to December 2021.
Methodology: A descriptive, retrospective, cross-sectional study was conducted among pregnant women diagnosed with preeclampsia, including a sample of 143 pregnant women.
Results: Pregnant women with preeclampsia were predominantly in the 20-34 age group, with higher education, and nulliparous women. Dystocic labor and preterm births were prevalent. The most frequently found risk factors were nulliparity, overweight and obesity, and chronic hypertension. A decrease in IgG and IgM immunoglobulins and complement protein C3 was found in most pregnant women.
Conclusion: Preeclampsia is determined by various epidemiological, clinical, and immunological factors, among others. These factors, when combined, allow us to establish strategies for essential preconception follow-up in primary health care, perform the necessary prenatal checkups, achieve early diagnosis, and thus prevent severe forms and complications in the mother-child relationship.
Downloads
References
1. Ford ND, Cox S, Ko JY, Ouyang L, Romero L, Colarusso T, et al. Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization - United States, 2017-2019. MMWR Morb Mortal Wkly Rep [Internet]. 2022 [citado 21/12/2024]; 71(17): [aprox. 3p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35482575/
https://doi.org/10.15585/MMWR.MM7117A1
2. Te Whatu Ora - Health New Zealand. Diagnosis and Treatment of Hypertension and Pre-eclampsia in Pregnancy in Aotearoa New Zealand: A clinical practice guideline [Internet]. New Zealand: Te Whatu Ora- Health New Zealand; 2022 [citado 21/12/2024]. Disponible en: https://www.tewhatuora.govt.nz/publications/diagnosis-and-treatment-of-hypertension-and-pre-eclampsia-in-pregnancy-in-aotearoa-new-zealand
3. Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens [internet]. 2022 [citado 21/12/2024]; 27: [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35066406/
https://10.1016/j. preghy.2021.09.008
4. Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. BMJ [Internet]- 2023 [citado 21/12/2024]; 381: e071653. Disponible en: https://www.bmj.com/content/381/bmj-2022-071653.abstract
https://dx.doi.org/10.1136/ bmj-2022-071653.
5. Rigol Ricardo O, Santisteban Alba SR. Obstetricia y Ginecología. 4a ed [Internet]. La Habana: Editorial Ciencias Médicas; 2023 [citado 18/04/2025]. Disponible en. https://www.bvscuba.sld.cu/libro/obstetricia-y-ginecologia-cuarta-edicion/
6. Tamil Barathi P, Mohanapriya A. Pre-eclampsia: Re-visiting pathophysiology, role of immune cells, biomarker identification and recent advances in its management. Journal of Reproductive Immunogy [Internet]. 2024 [citado 18/04/2025]; 163: [aprox. 2p.] Disponible en: https://europepmc.org/article/med/38555746
https://doi.org/10.1016/j.jri.2024.104236
7. Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol [Internet]. 2022 [citado 18/04/2025]; 226(2S): S1222-S1236. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32828743/
https://10.1016/j. ajog.2020.08.018
8. Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, et al. A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). Int J Gynaecol Obstet [Internet]. 2021 [citado 18/04/2025]; 154(Suppl 1):[aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34327714/
9. Aguilar-Esenarro A, Contretas-Rojas M, Calle-Dávila-de-Saavedra, M. Guía Técnica para la Valoración Nutricional Antropométrica de la gestante [Internet]. Perú: Ministerio de Salud; 2019 [citado 18/04/2025]. Disponible en: https://repositorio.ins.gob.pe/items/fde3f28f-09f0-422c-bb7c-db70b760767f
10. Cérbulo-Vázquez A, Anaya-Herrera J, Flores-Cánovas Y, Briones-Vega CG, Zavala-Barrios B, Carrillo-Esper R. Aspectos inmunológicos en preeclampsia. Rev Fac Med (Mex) [Internet]. 2023 [citado 18/04/2025]; 66(5): [aprox. 2p.] Disponible en: https://www.scielo.org.mx/scielo.php?pid=S0026-17422023000500007&script=sci_arttext
https://doi.org/10.22201/fm.24484865e.2023.66.5.02
11. Wang J, Han T, Zhu X. Role of maternal-fetal immunetolerance in the establishment and maintenance of pregnancy. Chin Med J (Engl) [Internet] 2024 [citado 08/03/2025]; 137(12):1399-1406. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11188918/
https://doi.org/10.1097/CM9.0000000000003114
12. Robles RG. Epidemiología de la preeclampsia en una muestra de gestantes de Bogotá (Colombia). Univ Med [Internet]. 2020 [citado 18/04/2025]. Disponible en: https://revistas.javeriana.edu.co/index.php/vnimedica/article/view/31201
13. Tornes YLF, Vega MMM, Fernández AMF, Pérez ETM. Prevalencia y caracterización de la preeclampsia. Rev Cub Obstet Ginecol [Internet]. 2022 [citado 18/04/2025]; 47(3):[aprox. 2p.]. Disponible en: https://www.revginecobstetricia.sld.cu/index.php/gin/article/view/889
14. De Jesús García AD, Jiménez Báez MV, González Ortiz DG, De La Cruz Toledo P l, Sandoval Jurado L, Kuc Peña LM. Características clínicas, epidemiológicas y riesgo obstétrico de pacientes con preeclampsia-eclampsia. Rev Enfer Inst Méx Seg Soc [Internet]. 2018 [citado 18/03/2024]; 26(4):[aprox. 2p.]. Disponible en: https://biblat.unam.mx/es/revista/revista-de-enfermeria-del-instituto-mexicano-del-seguro-social/articulo/caracteristicas-clinicas-epidemiologicas-y-riesgo-obstetrico-de-pacientes-con-preeclampsia-eclampsia
15. Arriaga García P, Montes Martínez V. Prevalencia de las categorías de hipertensión inducida por el embarazo que preceden a la eclampsia. Ginecol Obstet Méx [Internet]. 2021 [citado 18/03/2024]; 89(5):[aprox. 3p.]. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0300-904120
https://doi.org/10.24245/gomv89i5.4679
16. Medina J, Soto M, Torres O, Saravia C. Factores de riesgo para preeclampsia en un hospital general de Ica, Perú. Revista médica [internet] 2021 [citado 18/03/2024]; 10(1): [aprox. 3p.]. Disponible en: https://revistas.unica.edu.pe/index.php/panacea/article/view/397 https://doi.org/10.35563/rmp.v10i1.397
17. Mejía Hinostroza CM, Cámara Reyes AT. Obesidad como factor de riesgo asociado a preeclampsia en el servicio de ginecología y obstetricia en pandemia, en el periodo marzo 2020 a marzo 2021 en el Hospital Nacional Docente Madre Niño San Bartolomé [Tesis]. Lima: Universidad Ricardo Palma; 2022 [citado 18/03/2025]. Disponible en: https://repositorio.urp.edu.pe/handle/20.500.14138/5334
18. Suárez González JA, Gutiérrez Machado M. Indicadores de riesgo aterogénico en la preeclampsia. CorSalud [Internet]. 2021 [citado 18/03/2024]; 13(4): [aprox. 2p.]. Disponible en: https://revcorsalud.sld.cu/index.php/cors/article/view/629
19. Villegas Calero JC, Gadvay Requelme AS, Agudo Gonzabay BM. Actualización de los principales factores asociados a preeclampsia. Pol Con [Internet]. 2023 [citado 18/03/2024]; 8(2): [aprox. 2p.]. Disponible en: https://polodelconocimiento.com/ojs/index.php/es/article/view/5179
20. García Hermida MI, García Remirez CG, García Ríos CA. Comportamiento clínico epidemiológico de gestantes adolescentes con hipertensión arterial. Arch Méd Camagüey [Internet]. 2020 [citado 18/03/2025]; 24(4): [aprox. 2p.]. Disponible en: https://revistaamc.sld.cu/index.php/amc/article/view/7571
21. Blanco E, Marín M, Núñez L, Retamal E, Ossa X, Woolley KE, et al. Adverse pregnancy and perinatal outcomes in Latin America and the Caribbean: systematic review and meta-analysis. Rev Panam Salud Pub [Internet]. 2022 [citado 18/03/2025]; 46:e21. Disponible en. https://pubmed.ncbi.nlm.nih.gov/35509645/
https://doi.org/10.26633/rpsp.2022.21
22. Avila D, Salazar L. El sistema inmune en la gestación normal y en la preeclampsia. Rev Latin Perinat [Internet]. 2024 [citado 18/03/2025]; 27(3): [aprox. 2p.].
23. Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol [Internet]. 2022 [citado 18/03/2025]; 226(2S): S1019-S1034. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33096092/
https://10.1016/j.ajog.2020.10.022
24. Ibrahim A, Khoo MI, Ismail EHE, Nik Hussain NH, Mat Zin AA, Noordin L, et al. Oxidative stress biomarkers in pregnancy: a systematic review. Reprod Biol Endocrinol [Internet]. 2024 [citado 18/03/2025]; 22:[aprox. 2p.]. Disponible en: https://link.springer.com/article/10.1186/s12958-024-01259-x
https://doi.org/10.1186/s12958-024-01259-x
25. Yang H, Mo A, Guo Y, Li B , Liu C, Qu D. NLRP3 inflammasome in peripheral blood monocytes as a risk factor for early -onset preeclampsia. BMC Pregnancy and Childbirth [Internet]. 2023 [citado 18/03/2025]; 23(1):[aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37226086/
https://doi.org/10.1186/s12884-023-05606-5
26. X Wei, X Yang. The central role of natural killer cells in preeclampsia. Frontiers in Immunology [Internet]. 2023 [citado 18/03/2025]; 14: [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36865565/
https://frontiersin.org/2023.1009867
27. D Miller, K Motomura, J Galaz. Cellular immune responses in the pathophysiology of preeclampsia. Journal of Leukocyte Biology [Internet]. 2022 [citado 18/03/2025]; 111(1): [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36865565/
https://doi.org/10.3389/fimmu.2023.1009867
28. Salazar-Torres L, Gómez-Hernández T, Bequer-Mendoza L, Heredia-Ruiz D, Fernández-Caraballo D, Pérez de Alejo-Rodríguez L, et al. Comparación del nivel de marcadores inmunológicos entre recién nacidos con bajo peso de madres hipertensas y no hipertensas. Rev Mex Patol Clin Med Lab [Internet]. 2014 [citado 18/03/2025]; 61(4): [aprox. 5p.]. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=52584
29. Abul K. Abbas, Jordan S. Pober y Andrew H. Lichtman. CELLULAR AND MOLECULAR IMMUNOLOGY, 2022. Chapter 13: Effector Mechanisms of Humoral Immunity. TENTH EDITION, Elsevier Inc. ISBN: 978-0-323-75748-5. Disponible en: https://ebooks.elsevier.com
30. Reyna-Villasmil E, Briceño-Pérez C, Torres-Cepeda D. Inmunología, inflamación y preeclampsia. Rev Obstet Ginecol [Internet]. 2016 [citado 18/03/2025] 69(2):[aprox. 2p]. Disponible en: https://ve.scielo.org/scielo.php?script=sci_arttext&pid=S004877322009000200005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dayana Ruiz Luís, Lay Salazar Torres

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).